| Amerise Biosciences Ltd | Industry : (Finance) | |
|---|---|---|
|
BSE Code : 531681 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE673C01020 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 0.81 |
Market Cap(₹Cr) : 5.29 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Operating Income | 0.04 | 0.01 | 9.58 | - | - |
| Other Income | - | - | - | -0.17 | - |
| Total Income | 0.04 | 0.01 | 9.58 | -0.17 | - |
| EXPENDITURE : | |||||
| Operating & Administration Expenses | 0.09 | 0.11 | 8.97 | 0.07 | 0.11 |
| Miscellaneous Expenses | 0.02 | - | - | 0.06 | - |
| Interest | - | - | - | - | - |
| Less: Pre-operative Expenses Capitalised | - | - | - | - | - |
| Employee Expense | 0.07 | 0.02 | 0.05 | 0.04 | 0.04 |
| Total Expenditure | 0.18 | 0.13 | 9.02 | 0.17 | 0.15 |
| Gross Profit | -0.15 | -0.12 | 0.55 | -0.34 | -0.15 |
| Depreciation | - | - | - | - | - |
| Profit Before Tax | -0.15 | -0.12 | 0.55 | -0.34 | -0.15 |
| Current Tax | - | - | - | - | - |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | - | - | - | - | - |
| Reported Net Profit | -0.15 | -0.12 | 0.55 | -0.34 | -0.15 |
| Extraordinary Items | - | - | - | - | - |
| Adjusted Net Profit | -0.15 | -0.12 | 0.55 | -0.34 | -0.15 |
| Adjustment below net profit | - | - | - | - | - |
| Profit/Loss Balance brought forward | -1.17 | -1.05 | -1.60 | -1.26 | -1.11 |
| Appropriations | - | - | - | - | - |
| P & L Balance carried down | -1.31 | -1.17 | -1.05 | -1.60 | -1.26 |
| Dividend | - | - | - | - | - |
| Preference Share Dividend | - | - | - | - | - |
| Equity Dividend Rate (%) | - | - | - | - | - |
| Dividend Per Share(Rs) | - | - | - | - | - |
| Earnings Per Share-Unit Curr | -0.02 | -0.02 | 0.08 | -0.05 | -0.02 |
| Earnings Per Share(Adj)-Unit Curr | -0.02 | -0.02 | 0.08 | -0.05 | -0.02 |
| Book Value-Unit Curr | 0.81 | 0.84 | 0.85 | 0.77 | 0.82 |
| Book Value(Adj)-Unit Curr | 0.81 | 0.84 | 0.85 | 0.77 | 0.82 |